Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
CRISPR Therapeutics AG (CRSP) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.89M |
|
$-208.55M |
|
-- |
|
$0.89M |
|
$230.22M |
|
$-229.32M |
|
$22.07M |
|
$-207.26M |
|
$-207.26M |
|
$-208.55M |
|
$-208.55M |
|
$-208.55M |
|
$-208.55M |
|
$-229.32M |
|
$-224.68M |
|
87.07M |
|
87.07M |
|
$-2.40 |
|
$-2.40 |
|
| Balance Sheet Financials | |
$1.73B |
|
$124.93M |
|
$296.05M |
|
$2.03B |
|
$104.36M |
|
-- |
|
$214.22M |
|
$318.59M |
|
$1.71B |
|
$1.71B |
|
$1.71B |
|
88.38M |
|
| Cash Flow Statement Financials | |
$-167.83M |
|
$50.22M |
|
$12.85M |
|
$309.78M |
|
$205.14M |
|
$-104.64M |
|
$37.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.61 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
100.00% |
|
-25708.97% |
|
-25708.97% |
|
-- |
|
-23235.09% |
|
-23379.93% |
|
$-168.15M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-12.19% |
|
-12.19% |
|
-10.27% |
|
-12.19% |
|
$19.36 |
|
$-1.93 |
|
$-1.93 |
|